AbbVie’s pending Allergan takeover moves closer after drug divestments
28-01-2020
AbbVie to acquire Allergan for $63bn
25-06-2019
rafapress / Shutterstock.com
Allergan has struck a deal with two generic manufacturers to resolve a long-running patent infringement suit over its antidepressant drug Fetzima (Levomilnacipran).
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Allergan, Fetzima, US District Court for the District of New Jersey, MSN Laboratories, Aurobindo Pharma, generics
